NIH to Start Ebola Vaccine Study With Glaxo, Merck

The National Institutes of Health detailed its plans to test an Ebola vaccine on thousands of Liberians, with the help of two major drug companies, GlaxoSmithKline and Merck.



from WSJ.com: US Business http://ift.tt/15jIqxb

via IFTTT